Manuscripts
Showing 1543 manuscripts.
Ex vivo modeling of the effects of mycophenolic acid on HIV infection: considerations for antiviral therapy
Citation
Rupinderjeet J. Kaur, V. Klichko, David M. Margolis. Ex vivo modeling of the effects of mycophenolic acid on HIV infection: considerations for antiviral therapy. AIDS Research and Human Retroviruses. 2005. 21: 116-24.Year
2005
Journal
AIDS Research and Human Retroviruses
Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America
Citation
Lynda Anne Szczech, Samir K. Gupta, Joseph A. Eustace, Jonathan A. Winston, Ivy I. Boydstun, Tejinder S. Ahuja, Rudolph Rodriguez, Karen T. Tashima, Michelle E. Roland, Nora Franceschini, Frank Palella, Jeffrey L. Lennox, Paul E. Klotman, Sharon Appelbaum Nachman, Stephen D Hall. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clinical Infectious Diseases. 2005. 40: 1559-85.Year
2005
Journal
Clinical Infectious Diseases
HIV-1 pol replication capacity predicts disease progression
Citation
Eric S Daar, Karen L. Kesler, Terri Wrin, Christos J. Petropoulos, Michael P. Bates, Alice Lail, Nicholas S. Hellmann, Edward Gomperts, Sharyne Donfield. HIV-1 pol replication capacity predicts disease progression. AIDS. 2005. 19: 871-7.Year
2005
Journal
AIDS
HIV-associated wasting in the era of highly active antiretroviral therapy: a syndrome of residual HIV infection in monocytes and macrophages?
Citation
Cecilia M. Shikuma, Victor G. Valcour, Silvia Ratto-Kim, Andrew Williams, Scott Souza, Mariana Gerschenson, Larry Day, Jerome H. Kim, Bruce Shiramizu. HIV-associated wasting in the era of highly active antiretroviral therapy: a syndrome of residual HIV infection in monocytes and macrophages?. Clinical Infectious Diseases. 2005. 40: 1846-8.Year
2005
Journal
Clinical Infectious Diseases
Prevalence of elevated cholesterol and associated risk factors among perinatally HIV-infected children (4-19 years) in PACTG 219C.
Citation
John J. Farley, Philimon Gona, Marilyn Jean Crain, Joseph S. Cervia, James M. Oleske, George Seage, Jane C. Lindsey. Prevalence of elevated cholesterol and associated risk factors among perinatally HIV-infected children (4-19 years) in PACTG 219C.. Journal of Acquired Immune Deficiency Syndromes. 2005. 38: 480-487.Year
2005
Journal
Journal of Acquired Immune Deficiency Syndromes
Persistence of Nevirapine Exposure During the Postpartum Period After Intrapartum Single Dose Nevirapine In Addition to Zidovudine Prophylaxis for the Prevention of Mother-to-Child Transmission of HIV-1.
Citation
Tim Roy Cressey, Gonzague A. Jourdain, Marc Lallemant, Suparat Kunkeaw, Brooks Jackson, Edmund Capparelli, Philippa Musoke, Mark Mirochnick, Edmund Capparelli, Mark Mirochnick. Persistence of Nevirapine Exposure During the Postpartum Period After Intrapartum Single Dose Nevirapine In Addition to Zidovudine Prophylaxis for the Prevention of Mother-to-Child Transmission of HIV-1.. Journal of Acquired Immune Deficiency Syndromes. 2005. 38: 283-288.Year
2005
Journal
Journal of Acquired Immune Deficiency Syndromes
Immune reconstitution after receipt of highly active antiretroviral therapy in children with advanced or progressive HIV disease and complete or partial viral load response.
Citation
Andrea Kovacs, Grace Montepiedra, Vincent J. Carey, Savita G. Pahwa, Adriana Weinberg, Lisa M. Frenkel, Edmund Capparelli, Lynne M. Mofenson, Elizabeth (Betsy) Smith, Kenneth McIntosh, Sandra K. Burchett. Immune reconstitution after receipt of highly active antiretroviral therapy in children with advanced or progressive HIV disease and complete or partial viral load response.. Journal of Infectious Diseases. 2005. 192: 296-302.Year
2005
Journal
Journal of Infectious Diseases
Immune reconstitution and predictors of virologic failure in adolescents infected through risk behaviors and initiating HAART: week 60 results from the PACTG 381 cohort.
Citation
Bret J. Rudy, Jane C. Lindsey, Patricia M. Flynn, Ronald J. Bosch, Craig M. Wilson, Michael Hughes, Steven D. Douglas. Immune reconstitution and predictors of virologic failure in adolescents infected through risk behaviors and initiating HAART: week 60 results from the PACTG 381 cohort.. AIDS Research and Human Retroviruses. 2005. 22: 213-221.Year
2005
Journal
AIDS Research and Human Retroviruses
Clinical validation of the NeuroScreen
Citation
Ronald J. Ellis, Scott Evans, David B. Clifford, Lauren Moo, Justin C. McArthur, Ann C. Collier, Constance A. Benson, Ronald J. Bosch, David M. Simpson, Constantin Yiannoutsos, Yijun Yang, Kevin R. Robertson. Clinical validation of the NeuroScreen. Journal of Neurovirology. 2005. 11: 203-11.Year
2005
Journal
Journal of Neurovirology